Propelling Innovative Therapeutics to Help Cancer Patients
Dr. Patricia LoRusso works to find innovative therapeutics to reduce the toll of cancer on patients and their families.
Tag: Lung cancer
Dr. Patricia LoRusso works to find innovative therapeutics to reduce the toll of cancer on patients and their families.
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
Thursday, Feb. 4 is World Cancer Day, an initiative by the Union for International Cancer Control (UICC) to raise...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
It’s that time of year when we reflect on the progress we made over the past 12 months –...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic...